🇺🇸 FDA
Pipeline program

CMS

Z7224L01

Phase 3 small_molecule completed

Quick answer

CMS for Non Cystic Fibrosis Bronchiectasis is a Phase 3 program (small_molecule) at Zambon SpA with 1 ClinicalTrials.gov record(s).

Program details

Company
Zambon SpA
Indication
Non Cystic Fibrosis Bronchiectasis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials